Notably, in our model, in which cancer cells were treated with mTOR inhibitors, these adapted DNA methylation profiles underwent further changes, which may be partially connected to the antitumour effects of mTOR inhibitors and explain why drug resistance develops rapidly in some cases. This evidence concerns the gene MTOR and cancer.